Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | ||
Ligand | BDBM285629 | ||
Substrate/Competitor | n/a | ||
IC50 | 1550±n/a nM | ||
Citation | Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM Imidazopyridazine compounds US Patent US9598421 Publication Date 3/21/2017 | ||
More Info.: | Get all data from this article, Assay Method | ||
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | |||
Name: | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | ||
Synonyms: | 3',5'-cyclic phosphodiesterase | DPDE3 | PDE43 | PDE4D | PDE4D_HUMAN | Phosphodiesterase 4D | ||
Type: | Protein | ||
Mol. Mass.: | 91092.69 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q08499 | ||
Residue: | 809 | ||
Sequence: |
| ||
BDBM285629 | |||
n/a | |||
Name | BDBM285629 | ||
Synonyms: | 3-(4-cyano-5-fluoro-2-methylphenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide | US10077269, Example 99 | US10669279, Example 99 | US9598421, Example 99 | ||
Type | Small organic molecule | ||
Emp. Form. | C18H16FN5O | ||
Mol. Mass. | 337.3509 | ||
SMILES | CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(cc1C)C#N |(4.83,-5.68,;4.06,-4.34,;4.83,-3.01,;2.52,-4.34,;1.75,-3.01,;2.52,-1.67,;.21,-3.01,;-.7,-4.25,;-2.16,-3.78,;-3.49,-4.55,;-4.83,-3.78,;-4.83,-2.24,;-3.49,-1.47,;-2.16,-2.24,;-.7,-1.76,;-.3,-.27,;1.19,.12,;1.59,1.61,;3.08,2.01,;.49,2.8,;-.99,2.3,;-1.39,.81,;-2.87,.42,;.87,4.29,;1.25,5.78,)| | ||
Structure |